High Sensitivity C-Reactive Protein and Outcomes Following Percutaneous Coronary Intervention in Contemporary Practice | Zendy

Joerg Herrmann | Zendy; Ryan J. Len | Zendy; Gregory W. Barsness | Zendy; Gurpreet S. Sandhu | Zendy; Rajiv Gulati | Zendy; Patricia J.M. Best | Zendy; Paul Sorajja | Zendy; John F. Bresnahan | Zendy; Verghese Mathew | Zendy; Malcolm R. Bell | Zendy; Abhiram Prasad | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

High Sensitivity C-Reactive Protein and Outcomes Following Percutaneous Coronary Intervention in Contemporary Practice

Author(s) -

Joerg Herrmann,

Ryan J. Len,

Gregory W. Barsness,

Gurpreet S. Sandhu,

Rajiv Gulati,

Patricia J.M. Best,

Paul Sorajja,

John F. Bresnahan,

Verghese Mathew,

Malcolm R. Bell,

Abhiram Prasad

Publication year - 2012

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.112.972182

Subject(s) - medicine , percutaneous coronary intervention , myocardial infarction , hazard ratio , cardiology , c reactive protein , odds ratio , confidence interval , prospective cohort study , inflammation

High sensitivity C-reactive protein (hsCRP) has been identified as a predictor of adverse cardiovascular outcomes. Whether hsCRP is a useful biomarker for risk stratification in contemporary percutaneous coronary intervention remains unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research